Red Spruce Capital, LLC Neurocrine Biosciences Inc Transaction History

Red Spruce Capital, LLC

$206 Million
Q1 2025

A detailed history of Red Spruce Capital, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Red Spruce Capital, LLC holds 15,577 shares of NBIX stock, worth $2 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

15,577

Previous 15,921 2.16%

Holding current value

$2 Million

Previous $2.17 Million 20.75%

% of portfolio

0.84%

Previous 1.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$107.22 - $153.29 $36,883 - $52,731	-344 Reduced 2.16%	15,577 $1.72 Million
Q4 2024 Jan 17, 2025	BUY	$111.62 - $139.44 $1,674 - $2,091	15 Added 0.09%	15,921 $2.17 Million
Q3 2024 Oct 04, 2024	SELL	$114.58 - $153.15 $27,957 - $37,368	-244 Reduced 1.51%	15,906 $1.83 Million
Q2 2024 Jul 02, 2024	BUY	$130.86 - $143.19 $16,226 - $17,755	124 Added 0.77%	16,150 $2.22 Million
Q4 2023 Jan 05, 2024	BUY	$106.07 - $132.76 $10,713 - $13,408	101 Added 0.63%	16,026 $2.11 Million
Q2 2023 Jul 05, 2023	BUY	$89.53 - $104.87 $23,367 - $27,371	261 Added 1.67%	15,925 $1.5 Million
Q1 2023 Apr 06, 2023	BUY	$94.11 - $123.02 $36,326 - $47,485	386 Added 2.53%	15,664 $1.59 Million
Q4 2022 Jan 03, 2023	BUY	$106.72 - $127.06 $8,004 - $9,529	75 Added 0.49%	15,278 $0
Q3 2022 Oct 03, 2022	BUY	$92.03 - $107.81 $11,135 - $13,045	121 Added 0.8%	15,203 $1.62 Million
Q2 2022 Jul 05, 2022	BUY	$75.79 - $100.07 $17,280 - $22,815	228 Added 1.53%	15,082 $1.47 Million
Q1 2022 Apr 05, 2022	BUY	$72.45 - $94.81 $138,741 - $181,561	1,915 Added 14.8%	14,854 $1.39 Million
Q4 2021 Jan 03, 2022	BUY	$79.65 - $106.22 $95,022 - $126,720	1,193 Added 10.16%	12,939 $1.1 Million
Q3 2021 Oct 04, 2021	SELL	$86.18 - $99.03 $9,048 - $10,398	-105 Reduced 0.89%	11,746 $1.13 Million
Q1 2021 Apr 01, 2021	BUY	$87.57 - $119.4 $24,957 - $34,029	285 Added 2.46%	11,851 $1.15 Million
Q4 2020 Jan 04, 2021	BUY	$86.91 - $108.33 $36,676 - $45,715	422 Added 3.79%	11,566 $1.11 Million
Q3 2020 Oct 02, 2020	BUY	$96.16 - $135.15 $118,757 - $166,910	1,235 Added 12.46%	11,144 $1.07 Million
Q2 2020 Jul 02, 2020	BUY	$85.09 - $130.36 $3,063 - $4,692	36 Added 0.36%	9,909 $1.21 Million
Q1 2020 Apr 06, 2020	SELL	$75.11 - $113.76 $3,980 - $6,029	-53 Reduced 0.53%	9,873 $855,000
Q4 2019 Jan 16, 2020	BUY	$86.8 - $118.57 $861,576 - $1.18 Million	9,926 New	9,926 $1.07 Million

Others Institutions Holding NBIX

# of Institutions

649

Shares Held

97.6M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.

Account

Red Spruce Capital, LLC Neurocrine Biosciences Inc Transaction History